Clinical Trial Update: ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ctDNA-guided adjuvant chemotherapy for high-risk rectal cancer is not yet recruiting. The sponsor is Erasmus Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Erasmus Medical Center | Conditions: Rectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING